Lichen China Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Cash & Equivalents	25.86	22.6	16.85	8.67
Cash & Cash Equivalents	25.86	22.6	16.85	8.67
Cash Growth	14.41%	34.16%	94.40%	-
Receivables	4.46	3.55	4.36	2.83
Inventory	0.09	0.13	0.15	0.02
Other Current Assets	9.73	1	2.53	0.13
Total Current Assets	40.13	27.27	23.89	11.65
Property, Plant & Equipment	14.76	13.5	14.94	15.77
Goodwill and Intangibles	6.03	4.52	3.87	5.59
Other Long-Term Assets	4.63	1.24	0.25	0.34
Total Long-Term Assets	25.41	19.26	19.06	21.7
Total Assets	65.55	46.53	42.94	33.35
Accounts Payable	0.06	0.16	0.12	0.1
Deferred Revenue	1.03	1.15	1.27	1.1
Current Debt	0.1	0.09	0.35	0.34
Other Current Liabilities	2.9	3.84	4.37	4.17
Total Current Liabilities	4.09	5.23	6.11	5.71
Long-Term Debt	0.03	0.18	0	0
Other Long-Term Liabilities	0	0	-6.11	0
Total Long-Term Liabilities	0.03	0.18	-6.11	0
Total Liabilities	4.13	5.42	0	5.71
Total Debt	0.13	0.27	0.35	0.34
Debt Growth	-52.57%	-21.16%	2.37%	-
Retained Earnings	48.22	40.83	33.01	24.55
Comprehensive Income	-3.43	-2	1.54	0.81
Shareholders' Equity	61.42	41.11	36.83	27.64
Net Cash / Debt	25.73	22.33	16.5	8.33
Net Cash / Debt Growth	15.23%	35.32%	98.13%	-
Net Cash Per Share	0.99	0.99	0.73	0.37
Working Capital	36.04	22.04	17.78	5.95
Book Value Per Share	2.36	1.83	1.64	1.23

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).